Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort study

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) drugs have never been associated with erythrocytosis. In Eritrea, however, several cases of incident erythrocytosis had been observed in the MDR-TB hospital. This study was aimed at exploring the association between MDR-TB drugs and secondary ery...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesfamariam, Sirak, Ghebrenegus, Amon Solomon, Woldu, Henok, Fisseha, Ephrem, Belai, Gebremeskel, Russom, Mulugeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Tuberculosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611426/
https://www.ncbi.nlm.nih.gov/pubmed/34815231
http://dx.doi.org/10.1136/bmjresp-2021-001064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611426/
https://www.ncbi.nlm.nih.gov/pubmed/34815231
http://dx.doi.org/10.1136/bmjresp-2021-001064

Ejemplares similares